November 11-12 | In-Person & Digital (London) 

GLOBAL PHARMA AND BIOTECH SUMMIT

Industry leaders converge on London as biopharma navigates an era of unprecedented change

Save now with Early Bird rates

The global biopharma landscape is at an inflection point.

While AI-driven drug discovery promises to reshape R&D, and breakthroughs in obesity and rare diseases are transforming patient care, the industry also faces mounting headwinds — from regulatory obstacles, geopolitical tensions and shifting investor sentiment.

As the industry grapples with diverging policies across the US, EU, and Asia — including the proposed drug pricing reforms in the US and new EU regulations taking effect this year — the need for strategic clarity has never been more urgent.

The Global Pharma and Biotech Summit brings together the industry’s most influential voices to unpack these complex dynamics and chart a path forward. From C-suite executives recalibrating China strategies to investors rethinking deal structures in an uncertain market, we'll tackle the hard questions facing biopharma.

Whether you’re exploring next-gen gene therapies beyond CRISPR, scaling AI for real-world application, or navigating fractured regulatory environments, this is where you’ll find the latest roadmap direct from the front lines of biopharma.

What are the strategic decisions that will define the next decade of biopharma? Join us in London — in person or virtually — for real conversations in an uncertain reality.

Save now with Early Bird rates

Sponsors